Bracco, the market leader in diagnostic imaging and the pioneer in cardiac positron emission tomography (PET) for more than three decades, today affirmed its strong support of the newly published ...

The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio In low-risk patients, an exercise test ...

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), American Society of Nuclear Cardiology (ASNC), European Association of Nuclear Medicine (EANM), and American College of Nuclear Medicine ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Pharmacological stress agents are safe for people who ...

ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has delivered the first patient doses of Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission ...

The United States will likely adopt the strategies that other countries have already implemented to reduce radiation exposure related to myocardial perfusion imaging, which accounts for a major ...

One of the leading causes of death worldwide is cardiovascular diseases. In efforts to manage these heart-related diseases, eight techniques have been defined to help doctors more optimally use ...

Nuclear cardiac testing is most appropriate in the diagnosis of CAD in patients who have an intermediate likelihood of disease. Low-risk patients may need no additional testing, while high-risk ...

Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) Annual Scientific Session and Expo in New Orleans, March 28 to 30. The ...